2013 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
Nov 13, 2013
Kala’s Ocular Disease Program Selected as a Top 10 Project to Watch
Nov 12, 2013
Kala Pharmaceuticals Presents Preclinical Data on Mucus Penetrating Particles at 2013 AAPS Annual Meeting and Exposition
Nov 5, 2013
Kala Pharmaceuticals to Present at 5th Annual Ophthalmology Innovation Summit @ AAO
Oct 4, 2013
Kala Pharmaceuticals to Present at Partnership Opportunities in Drug Delivery conference
Oct 2, 2013
Kala Pharmaceuticals to Present at BIO Investor Forum
Sep 24, 2013
Kala Pharmaceuticals to Present at the Targeting Ocular Disorders Conference
Sep 23, 2013
Kala Pharmaceuticals to Present at the Targeting Ocular Disorders Conference
Aug 8, 2013
Kala Pharmaceuticals to Present at the Canaccord Genuity Annual Growth Conference
Jul 22, 2013
Kala Presents Data Demonstrating Topical Delivery to Posterior Segment of the Eye
Jul 19, 2013
Kala Pharmaceuticals to Present Data at the Controlled Release Society 2013 Annual Meeting
May 28, 2013
Kala Pharmaceuticals Appoints Charles McDermott as Executive Vice President of Business Development
May 6, 2013
Kala Presents Data on Enhanced Topical Ocular Delivery of a Receptor Tyrosine Kinase Inhibitor
Apr 23, 2013
Kala Pharmaceuticals Announces $22.5 Million Series B Financing
Mar 3, 2013
Kala Pharmaceuticals to Present Data at ARVO 2013 Annual Meeting
Feb 28, 2013
Kala Pharmaceuticals Secures $11.5 Million in Series A Financing
Feb 5, 2013
Kala Pharmaceuticals Receives Cystic Fibrosis Foundation Grant
Feb 5, 2013
Kala Pharmaceuticals Appoints Kim Brazzell, PhD, as Chief Medical Officer